attachment
attachment

Causes of such lesions since 10 days in kid of 2 years and same lesions in sibling of 2 years aswell

analyse_media
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Loading Image
Searching the Web

tungiasis jigger flea foot children nodule umbilicated clinical presentation

I now have a comprehensive picture. Here is the full clinical analysis:

Clinical Analysis

Image Findings (from analysis)

The lesions are on the lateral aspect of the right foot / dorsolateral midfoot, near the ankle. They are:
  • Raised, dome-shaped nodular papules, 5-12 mm
  • Centrally umbilicated or with central whitish-yellow core/punctum
  • Surrounded by post-inflammatory hyperpigmentation
  • Clustered in a localized area (3 lesions visible)

Key Clinical Context

  • Two siblings, both ~2 years old, affected simultaneously
  • Duration: 10 days
  • Location: feet/dorsal foot

Most Likely Diagnoses

1. TUNGIASIS (Jigger Flea - Tunga penetrans) - TOP DIFFERENTIAL for this presentation

This is the single most fitting diagnosis given:
  • Foot/ankle location (flea penetrates the feet preferentially, especially between toes, under toenails, and dorsal/lateral foot)
  • Nodular lesion with central dark/white punctum - the characteristic "caldera" appearance
  • Two siblings affected simultaneously - both children likely walked barefoot in the same sandy/soil environment
  • Tropical/subtropical setting implied (sub-Saharan Africa, India, Caribbean, Latin America)
  • 10-day duration matches the growth timeline of the embedded flea (Stage 3: flea hypertrophies over ~2 weeks)
  • The whitish-yellow center in one lesion represents the engorged flea body; the yellowish-white dot is the flea's posterior (anus/egg-release opening)
Mechanism: A fertilized female Tunga penetrans flea burrows into the epidermis of a barefoot child walking on sand/soil. The flea embeds and hypertrophies from 1 mm to pea-size while feeding on blood and producing hundreds of eggs. This creates a raised whitish nodule with a central black/dark punctum.
"The fleas are usually found between the toes or under toe nails, and humans acquire the infection when walking barefoot in tropical and subtropical regions." - CDC DPDx, Tungiasis
Complications if untreated: Superimposed cellulitis, abscess, gangrene, tetanus, difficulty walking.
Treatment: Sterile extraction of the embedded flea (gold standard) + local antiseptic. Topical dimeticone (kills flea by suffocation) is a safe alternative for multiple lesions. Check tetanus immunization status.

2. Molluscum Contagiosum - Important differential

  • Caused by poxvirus (MCV-1 in children aged 1-4 years, the highest-risk age group)
  • Most common in ages 1-4 years - matches these 2-year-olds perfectly
  • Presents as smooth, dome-shaped, pearly papules with central umbilication, 3-5 mm (larger "giant" lesions >1 cm possible)
  • Spread by direct skin-to-skin contact or shared fomites (towels, toys, water) - explains sibling transmission
  • "Even plantar lesions can be seen" and irritated lesions become crusted, pustular, and even simulate cellulitis - matches the appearance seen
Molluscum contagiosum - raised umbilicated papules
Fig. 19.32 - Molluscum contagiosum (Andrews' Diseases of the Skin)
Key point: The large size (5-12 mm, one up to 12 mm) and foot location with yellowish core slightly favor tungiasis or inflamed/giant MC. The "BOTE sign" (beginning of the end - inflammation before spontaneous resolution) can explain the crusted/pustular central appearance.
Treatment: Often self-limiting (resolves in months-years). Options include cryotherapy, curettage, cantharidin, topical imiquimod.
  • Andrews' Diseases of the Skin, p. 453-454
  • Tintinalli's Emergency Medicine, p. 1065

3. Papular Urticaria / Insect Bite Hypersensitivity

  • Intensely pruritic, firm, urticarial papules from insect bites (mosquitoes, fleas, mites)
  • Children are particularly susceptible due to lack of prior sensitization
  • Siblings in the same household would share the same insect exposure
  • Secondary changes (excoriation, secondary infection) can create crusted nodular lesions
  • Does NOT typically produce umbilicated papules - less likely here

4. Cutaneous Warts (Verruca plantaris/vulgaris)

  • HPV infection causing rough, keratotic papules
  • Can affect feet, but typically hyperkeratotic rather than umbilicated/pearly
  • Spread by contact - siblings could share

Summary Table

FeatureTungiasisMolluscum Contagiosum
Age groupAny, children most vulnerable1-4 years (peak)
LocationFeet (preferred)Anywhere, feet possible
LesionWhitish nodule, central dark/white punctumPearly papule, central umbilication
TransmissionBarefoot soil contactSkin contact, fomites
Both siblings affectedSame soil exposureDirect contact / fomites
Duration 10 daysMatches flea growth (2-3 wks to full size)Yes (new lesions appear over weeks)
Central yellow coreEngorged flea body/eggsCaseous white core (molluscum body)
TreatmentFlea extractionSelf-limiting / cryotherapy

Recommendation

Please have a dermatologist or pediatrician examine both children in person. The distinction between tungiasis and molluscum contagiosum is important because:
  • Tungiasis requires physical removal of the flea and carries risk of serious secondary infection including tetanus if untreated
  • Molluscum is generally benign and self-limiting but still benefits from treatment to prevent spread
If either child has been walking barefoot on soil/sand (especially in a tropical region), tungiasis should be ruled out first. A simple dermoscopy examination can confirm the presence of the embedded flea body and egg sacs.
⚠️ Disclaimer: This is general clinical information only and does not replace an in-person medical evaluation. Please see a qualified healthcare professional for diagnosis and treatment.
attachment
attachment
attachment
attachment
attachment
attachment

47 year old female post craniotomy 6 months for brain tumor has such lesions over both legs with mild itching with no history of diabetes and on meds for htn and anti epilepsy..what can be the possible diagnosis and management

analyse_media
analyse_media
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web

drug induced ichthyosis antiepileptic drugs phenytoin carbamazepine valproate skin xerosis mechanism management

Reading File
Reading Web Page

https://nsj.org.sa/content/nsj/10/4/268.full.pdf

Finding Sources
Finding Sources
Searching the Web

acquired ichthyosis post craniotomy immobility leg xerosis antiepileptic drug skin management emollients

I now have all the information needed for a thorough response. Let me compile the complete clinical analysis.

Clinical Analysis

Image Findings

Image 1 (thigh/knee area):
  • Diffuse lichenification with exaggerated skin markings (leathery texture)
  • Fine whitish-grey scaling
  • Post-inflammatory hyperpigmentation (brownish-grey)
  • Multiple excoriations with pinpoint hemorrhagic crusts from scratching
  • Confluent patches over anterior/lateral thigh extending to knee
Image 2 (leg - close up):
  • Widespread fine, powdery, diffuse scaling ("fish-scale" or "dusty" appearance)
  • Prominent follicular accentuation with darkened/plugged pores
  • Deep mottled hyperpigmentation (golden-brown to ash-grey)
  • Micro-fissuring of dry epidermis along tension lines
  • Subtle lichenification and pinpoint excoriations
This combination - bilateral, symmetric, diffuse xerosis + ichthyosis-like scaling + hyperpigmentation + pruritus over the legs in a woman on long-term AEDs - is a classic presentation.

Most Likely Diagnoses

1. Acquired Ichthyosis / Drug-Induced Xerosis-Ichthyosis - PRIMARY DIAGNOSIS

This is the most fitting diagnosis given the complete clinical context:
Mechanism via AEDs:
  • Phenytoin, carbamazepine, phenobarbital, and valproate are all known to interfere with vitamin D metabolism (CYP450 enzyme induction accelerates vitamin D catabolism), lipid metabolism, and epidermal barrier function
  • AEDs reduce skin ceramide synthesis and alter the lipid composition of the stratum corneum, leading to impaired barrier function, increased transepidermal water loss, and resultant compensatory hyperkeratosis and scaling
  • Chronic AED use is also associated with xerosis, pruritus, acneiform eruptions, and hyperpigmentation
  • The NSJ study on AED skin findings documented xerosis (12.9%) and pruritus (8.1%) among chronic AED users
Additional contributing factors in this patient:
  • Post-craniotomy immobility / reduced ambulation - venous stasis and reduced lymphatic flow worsen lower-limb skin changes
  • Systemic corticosteroids (commonly given perioperatively/post-craniotomy for cerebral edema) - these reduce skin lipid synthesis and barrier function
  • Antihypertensive drugs (certain calcium channel blockers like amlodipine, or beta-blockers) can also cause xerosis/pruritus
  • Reduced sun exposure and physical activity post-surgery impairs vitamin D synthesis further
  • Age-related (47 years - perimenopausal estrogen decline reduces skin hydration)
From Robbins Pathology: "Acquired (noninherited) variants also exist and may be associated with lymphoid and visceral malignancies" and systemic causes. The pathology shows "buildup of compacted and thickened stratum corneum...defective desquamation." - Robbins Pathologic Basis of Disease, p. 1063
Per Merck Manuals: "Acquired ichthyosis typically presents in adulthood...Some medications also cause ichthyosis (eg, nicotinic acid, triparanol, butyrophenones)."

2. Stasis Dermatitis - Important co-contributor

  • Post-craniotomy reduced mobility causes venous insufficiency in the legs
  • Presents as bilateral lower limb hyperpigmentation, scaling, pruritus, and lichenification
  • The mottled brownish hyperpigmentation seen is consistent with hemosiderin deposition from stasis
  • Highly likely to be co-existing with xerosis/ichthyosis here

3. Asteatotic Eczema (Eczema Craquelé) - Differential

  • Extreme dryness leading to cracked, fissured skin with superficial eczematous change
  • Common in patients with poor mobility, low humidity environments, and altered skin barrier
  • The micro-fissuring and scaling pattern seen in image 2 is consistent

4. Rule out: Statin-induced myopathy / Hypothyroidism-related ichthyosis

  • Hypothyroidism gives the same pattern (dry, scaly, thickened skin + myxedema); if on any medication post-craniotomy that could affect thyroid, TSH should be checked
  • Some antihypertensives (e.g., hydrochlorothiazide, propranolol) are photosensitizers that worsen xerosis

5. Malignancy-related acquired ichthyosis - must be excluded

  • This patient has a history of brain tumor - acquired ichthyosis in adults can be a paraneoplastic phenomenon associated with Hodgkin lymphoma, multiple myeloma, and other malignancies
  • If tumor is benign (e.g., meningioma), this is less likely but should be noted

Management

Immediate / Topical

TreatmentRegimenNotes
Emollients (white soft paraffin, mineral oil, aqueous cream)Apply twice daily, especially after bathing while skin is still dampMainstay of treatment - seals in moisture
Urea-based creams (10-25%)Once daily on thick/scaly areasKeratolytic + humectant; avoid on inflamed/fissured skin
Lactic acid cream (5-12%)Once dailyAlpha-hydroxy acid - keratolytic, improves hydration
Topical low-potency corticosteroid (hydrocortisone 1%)Short course to pruritic/eczematous areasFor itch relief; avoid long-term use
Soap substitutes / gentle cleansersReplace soap with emulsifying ointment or aqueous creamAvoid harsh soaps that strip skin lipids
Lukewarm baths (20-30 min)Daily or every other dayRemove scale; apply emollient immediately after

Systemic / Underlying Cause

  • Vitamin D supplementation - strongly recommended given AED-induced vitamin D deficiency (phenytoin, carbamazepine, phenobarbital are CYP450 inducers); recommended 1000-2000 IU/day
  • Antihistamines (cetirizine or loratadine) - for pruritus relief, non-sedating preferred
  • Encourage leg elevation and ambulation - addresses venous stasis component
  • Compression stockings (class I) - if stasis dermatitis component confirmed

Investigations to Order

InvestigationRationale
TSH / Free T4Rule out hypothyroidism (same clinical picture)
CBC, LFT, serum albuminScreen for systemic disease, nutritional status
Serum Vitamin D (25-OH)AED users frequently have low levels
Serum calcium, phosphateOften abnormal with AED-induced vitamin D deficiency
Fasting glucose / HbA1cEven without known diabetes, post-craniotomy patients may have glucose dysregulation; diabetic xerosis is common
AED drug levelsConfirm therapeutic range; toxicity worsens skin changes
Review antihypertensiveIdentify if calcium channel blocker (amlodipine can cause leg swelling/stasis), diuretic (worsens dryness), or beta-blocker (worsens Raynaud/peripheral circulation)

Drug Review

  • Discuss with the neurologist whether the AED type can be modified:
    • Enzyme-inducing AEDs (phenytoin, carbamazepine, phenobarbital) cause the most vitamin D depletion and skin changes
    • Newer AEDs (levetiracetam, lamotrigine, lacosamide) have fewer metabolic skin effects
    • Do not stop AEDs without neurology input - seizure risk post-craniotomy

Referral

  • Dermatology - for formal diagnosis, biopsy if atypical features, and supervised keratolytic therapy
  • Neurology / Oncology - ongoing tumor surveillance (rule out paraneoplastic ichthyosis)
  • Physiotherapy - mobility improvement to address stasis component

Summary

The most likely diagnosis is acquired ichthyosis/drug-induced xerosis from chronic AED use (accelerated vitamin D catabolism + impaired skin barrier), compounded by post-craniotomy immobility causing stasis dermatitis and possible antihypertensive contribution. The absent diabetes history makes diabetic dermopathy less likely. Hypothyroidism and paraneoplastic ichthyosis (in context of the known brain tumor) must be excluded by investigations.
First-line management: intensive emollient therapy + vitamin D supplementation + AED review + investigations as above.
⚠️ This is clinical guidance for healthcare professionals. All management decisions require in-person clinical assessment.
This is a shared conversation. Sign in to Orris to start your own chat.